Skip to main content

$0.125 (0.00%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
7 June 2025 at 9:40am
Register to track EMD and receive email alerts.

Emyria Partners with Thought Leaders in Psychedelic Therapy

StockBot

416,823 posts

EMD released this announcement to the ASX on 19 November 2020, 9:22. The announcement is marked as price sensitive, and is 3 page(s) in length and 203.11kb in size.

You can view all announcements from EMD and see how they appear on a price chart on the announcements page.

At the date of this announcement, EMD was 0.086% short sold according to ASIC data. It was ranked the 470th most shorted stock on the ASX. It remains ranked 600th as of the latest reported data (17 April 2025).

Other Recent Announcements from EMD
Trading Halt 29 June 2023, 9:33
Emyria Receives Ethics Approval for MDMA-assisted Therapy 8 June 2023, 9:10
Section 708A(5)(e) Notice 10 May 2023, 18:37
Emyria Partners with Thought Leaders in Psychedelic Therapy 19 November 2020, 9:22
Change of Director's Interest Notice SW 16 November 2020, 9:40
Change of Director's Interest Notice * 4 13 November 2020, 19:44
Appendix 3G 13 November 2020, 19:36
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EMD and receive email alerts.